Tilkal
Venture Round in 2024
Tilkal develops a software infrastructure that organizes traceability across various supply chain stakeholders. Founded in 2017, the company is headquartered in Paris, France.
Epigene Labs
Convertible Note in 2023
Epigene Labs SAS is a biotechnology firm focused on enhancing precision oncology through its advanced technology platform that utilizes artificial intelligence. Founded in 2019 and headquartered in Paris, France, with an additional office in Boston, Massachusetts, the company addresses the significant challenges of aggregating, analyzing, and visualizing extensive genomic data in cancer research. By integrating proprietary data from partners with publicly available datasets, Epigene Labs provides medical researchers with actionable insights and user-friendly analytics. The company collaborates with leading cancer centers and prominent biotech firms to develop intelligence-augmenting services that support drug discovery and research in precision oncology. Its innovative approach aims to transform genomic data into effective strategies for targeted cancer therapies.
Scipio Bioscience
Convertible Note in 2023
Scipio Bioscience SAS is a biotechnology company based in Paris, France, founded in 2017. It specializes in manufacturing benchtop kits that provide innovative sample preparation solutions for single-cell studies. These kits are designed for use in sequencing applications across both clinical and basic research, with a particular focus on transcriptomics. Scipio Bioscience's products enable research laboratories to perform single-cell barcoding in a test tube format, facilitating more precise and efficient analysis in various scientific investigations.
Ganymed Robotics
Series B in 2023
Ganymed Robotics is a medical device company that develops robotics technologies for orthopedic surgeons, including a therapeutic device designed to improve precision in knee replacement procedures. Founded in 2018 and based in Paris, the company aims to enhance surgical accuracy, reduce operating times, and improve patient outcomes by integrating robotics into the orthopedic workflow.
Tilkal
Venture Round in 2022
Tilkal develops a software infrastructure that organizes traceability across various supply chain stakeholders. Founded in 2017, the company is headquartered in Paris, France.
Tilkal develops a software infrastructure that organizes traceability across various supply chain stakeholders. Founded in 2017, the company is headquartered in Paris, France.
Ganymed Robotics
Series B in 2022
Ganymed Robotics is a medical device company that develops robotics technologies for orthopedic surgeons, including a therapeutic device designed to improve precision in knee replacement procedures. Founded in 2018 and based in Paris, the company aims to enhance surgical accuracy, reduce operating times, and improve patient outcomes by integrating robotics into the orthopedic workflow.
C12 Quantum Electronics
Grant in 2022
C12 Quantum Electronics is a company based in Paris, Ile-de-France, France, founded in 2019 by Pierre and Matthieu Desjardins. The company focuses on developing reliable quantum processors utilizing carbon nanotubes, which significantly reduce error rates. This technology positions C12 Quantum Electronics as a strong candidate for noisy intermediate-scale quantum applications. In addition to building quantum computers, the company also engages in developing and accelerating experiments related to information processing systems, allowing industrial clients to leverage intermediate-scale quantum applications for enhanced computing capabilities.
Qubit Pharmaceuticals
Seed Round in 2022
Qubit Pharmaceuticals is a Paris-based drug discovery company established in 2020. It develops a simulation platform that reduces the cost and duration of preclinical development by using proprietary force field models and molecular dynamics to perform virtual screening and visualization, enabling the identification of viable drug candidates. The platform applies quantum physics-inspired modeling to support biopharmaceutical research and aims to translate advanced computational methods into practical tools for drug development.
Core Biogenesis
Private Equity Round in 2022
Founded in Paris, France in 2020, Core Biogenesis specializes in developing protein production technologies. The company employs proprietary gene editing and plant biotechnology to significantly lower the cost of producing growth factors, which are crucial molecules in clean meat and cell therapy industries.
Scipio Bioscience
Venture Round in 2022
Scipio Bioscience SAS is a biotechnology company based in Paris, France, founded in 2017. It specializes in manufacturing benchtop kits that provide innovative sample preparation solutions for single-cell studies. These kits are designed for use in sequencing applications across both clinical and basic research, with a particular focus on transcriptomics. Scipio Bioscience's products enable research laboratories to perform single-cell barcoding in a test tube format, facilitating more precise and efficient analysis in various scientific investigations.
Scipio Bioscience
Grant in 2022
Scipio Bioscience SAS is a biotechnology company based in Paris, France, founded in 2017. It specializes in manufacturing benchtop kits that provide innovative sample preparation solutions for single-cell studies. These kits are designed for use in sequencing applications across both clinical and basic research, with a particular focus on transcriptomics. Scipio Bioscience's products enable research laboratories to perform single-cell barcoding in a test tube format, facilitating more precise and efficient analysis in various scientific investigations.
Core Biogenesis
Venture Round in 2022
Founded in Paris, France in 2020, Core Biogenesis specializes in developing protein production technologies. The company employs proprietary gene editing and plant biotechnology to significantly lower the cost of producing growth factors, which are crucial molecules in clean meat and cell therapy industries.
Core Biogenesis
Grant in 2022
Founded in Paris, France in 2020, Core Biogenesis specializes in developing protein production technologies. The company employs proprietary gene editing and plant biotechnology to significantly lower the cost of producing growth factors, which are crucial molecules in clean meat and cell therapy industries.
Founded in 2019, EVerZom is a Paris-based biotech company specializing in nanomedicine. It develops and manufactures extracellular vesicles (exosomes, microvesicles, apoptotic bodies) at commercial scale under Good Manufacturing Practice (GMP) standards for pharmaceutical applications in regenerative medicine and drug delivery.
Ganymed Robotics
Grant in 2021
Ganymed Robotics is a medical device company that develops robotics technologies for orthopedic surgeons, including a therapeutic device designed to improve precision in knee replacement procedures. Founded in 2018 and based in Paris, the company aims to enhance surgical accuracy, reduce operating times, and improve patient outcomes by integrating robotics into the orthopedic workflow.
Epigene Labs
Grant in 2021
Epigene Labs SAS is a biotechnology firm focused on enhancing precision oncology through its advanced technology platform that utilizes artificial intelligence. Founded in 2019 and headquartered in Paris, France, with an additional office in Boston, Massachusetts, the company addresses the significant challenges of aggregating, analyzing, and visualizing extensive genomic data in cancer research. By integrating proprietary data from partners with publicly available datasets, Epigene Labs provides medical researchers with actionable insights and user-friendly analytics. The company collaborates with leading cancer centers and prominent biotech firms to develop intelligence-augmenting services that support drug discovery and research in precision oncology. Its innovative approach aims to transform genomic data into effective strategies for targeted cancer therapies.
PKvitality
Series A in 2021
PKvitality is a French bio-wearable company founded in 2017. It specializes in developing non-invasive health monitoring devices, notably the K’Watch Glucose, a smartwatch that enables diabetic patients to monitor their glucose levels painlessly and discreetly.
Oledcomm
Venture Round in 2021
Oledcomm designs and develops LiFi solutions that enable high-speed optical wireless data communication for aerospace and industrial markets. Its product portfolio includes LiFi transceivers, software, and LiFi network interface devices that convert information into binary data for fast, secure wireless transmission in telecom, datacom, consumer electronics, and industrial applications, especially where radio waves are undesirable. Founded in 2012 and based in Paris, France, the company was re-founded in 2020 by Benjamin Azoulay.
Aenitis Technologies
Grant in 2021
A French startup created by CNRS researchers at the Physics and Mechanics of Heterogeneous Media (PMMH) Laboratory in Paris, Aenitis Technologies develops bioprocessing medical devices that use acoustophoresis to separate, manipulate and filter biological elements, with a focus on cell therapy manufacturing such as cell sorting, washing and isolation for cell therapy units and blood banks. The company aims to provide acoustic preparation solutions to streamline cell therapies and advance public health, pursuing leadership in acoustophoresis-based separation.
Qubit Pharmaceuticals
Grant in 2021
Qubit Pharmaceuticals is a Paris-based drug discovery company established in 2020. It develops a simulation platform that reduces the cost and duration of preclinical development by using proprietary force field models and molecular dynamics to perform virtual screening and visualization, enabling the identification of viable drug candidates. The platform applies quantum physics-inspired modeling to support biopharmaceutical research and aims to translate advanced computational methods into practical tools for drug development.
Oledcomm designs and develops LiFi solutions that enable high-speed optical wireless data communication for aerospace and industrial markets. Its product portfolio includes LiFi transceivers, software, and LiFi network interface devices that convert information into binary data for fast, secure wireless transmission in telecom, datacom, consumer electronics, and industrial applications, especially where radio waves are undesirable. Founded in 2012 and based in Paris, France, the company was re-founded in 2020 by Benjamin Azoulay.
PKvitality is a French bio-wearable company founded in 2017. It specializes in developing non-invasive health monitoring devices, notably the K’Watch Glucose, a smartwatch that enables diabetic patients to monitor their glucose levels painlessly and discreetly.
Aenitis Technologies
Seed Round in 2015
A French startup created by CNRS researchers at the Physics and Mechanics of Heterogeneous Media (PMMH) Laboratory in Paris, Aenitis Technologies develops bioprocessing medical devices that use acoustophoresis to separate, manipulate and filter biological elements, with a focus on cell therapy manufacturing such as cell sorting, washing and isolation for cell therapy units and blood banks. The company aims to provide acoustic preparation solutions to streamline cell therapies and advance public health, pursuing leadership in acoustophoresis-based separation.